Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy.

Nick Miller, Laura McWhirter, Jon Stone, Alan Carson, Anne Vertigan, Miriam van Mersbergen, Rene Utianski, Jennifer Short, Nelson Roy, Carole Roth, Jo Patterson, Janet Baker, Kirsty McKenzie, Catherine Gregory, Jennifer L Freeburn, Diane E Fraser, Annie Elias, Joseph R Duffy, Lorna Dixon, Maria Dietrich, Lesley Cavalli, Caroline Barnett

Journal: Journal of neurology, neurosurgery, and psychiatry 2022;92(10):1112-1125

PMID: 34210802

Abstract

["Communication problems (eg, dysphonia, dysfluency and language and articulation disorders), swallowing disorders (dysphagia and globus), cough and upper airway symptoms, resulting from functional neurological disorder (FND), are commonly encountered by speech and language professionals. However, there are few descriptions in the literature of the most effective practical management approaches. This consensus document aims to provide recommendations for assessment and intervention that are relevant to both adults and young people. An international panel of speech and language professionals with expertise in FND were approached to take part. Participants responded individually by email to a set of key questions regarding best practice for assessment and interventions. Next, a video conference was held in which participants discussed and debated the answers to these key questions, aiming to achieve consensus on each issue. Drafts of the collated consensus recommendations were circulated until consensus was achieved. FND should be diagnosed on the basis of positive clinical features. Speech and language therapy for FND should address illness beliefs, self-directed attention and abnormal movement patterns through a process of education, symptomatic treatment and cognitive behavioural therapy within a supportive therapeutic environment. We provide specific examples of these strategies for different symptoms. Speech and language professionals have a key role in the management of people with communication and related symptoms of FND. It is intended that these expert recommendations serve as both a practical toolkit and a starting point for further research into evidence-based treatments.",{"copyright":"\u00a9 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ."}]
Address: Speech Pathology, Flinders University, Adelaide, South Australia, Australia.; University of Technology Sydney, Sydney, New South Wales, Australia.; South Warwickshire NHS Foundation Trust, Warwick, Warwickshire, UK.; Department of Speech & Language Therapy, Great Ormond Street Hospital for Children NHS Foundation Trust, London, London, UK.; Division of Psychology and Language Sciences, University College London, London, London, UK.; Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany.; National Hospital for Neurology and Neurosurgery, London, London, UK.; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Speech and Language Therapy, Kent Community Health NHS Foundation Trust, Ashford, Kent, UK.; Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh, Edinburgh, UK.; Massachusetts General Hospital, Boston, Massachusetts, USA.; Lewisham and Greenwich NHS Trust, London, London, UK.; Speech Language Sciences, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.; University of Liverpool, Liverpool, Merseyside, UK.; Speech Pathology Division, Naval Medical Center San Diego, San Diego, California, USA.; Department of Communication Sciences and Disorders, The University of Utah, Salt Lake City, Utah, USA.; Division of Otolaryngology - Head and Neck Surgery (Adjunct), The University of Utah, Salt Lake City, Utah, USA.; North Bristol NHS Trust, Westbury on Trym, Bristol, UK.; Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Speech Pathology and Neurology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.; School of Communication Sciences and Disorders, Institute for Intelligent Systems, The University of Memphis, Memphis, Tennessee, USA.; Speech Pathology, John Hunter Hospital, Newcastle, New South Wales, Australia.; Centre for Healthy Lungs, Hunter Medical Research Institute; School of Medicine and Public Health, The University of Newcastle, Newcastle, New South Wales, Australia.; Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Edinburgh, UK.; Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Edinburgh, UK [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.